1. Home
  2. XOMAP vs TALKW Comparison

XOMAP vs TALKW Comparison

Compare XOMAP & TALKW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMAP
  • TALKW
  • Stock Information
  • Founded
  • XOMAP N/A
  • TALKW 2012
  • Country
  • XOMAP United States
  • TALKW United States
  • Employees
  • XOMAP 13
  • TALKW N/A
  • Industry
  • XOMAP Biotechnology: Pharmaceutical Preparations
  • TALKW Medical/Nursing Services
  • Sector
  • XOMAP Health Care
  • TALKW Health Care
  • Exchange
  • XOMAP Nasdaq
  • TALKW Nasdaq
  • Market Cap
  • XOMAP N/A
  • TALKW N/A
  • IPO Year
  • XOMAP N/A
  • TALKW N/A
  • Fundamental
  • Price
  • XOMAP $25.62
  • TALKW $0.16
  • Analyst Decision
  • XOMAP
  • TALKW
  • Analyst Count
  • XOMAP 0
  • TALKW 0
  • Target Price
  • XOMAP N/A
  • TALKW N/A
  • AVG Volume (30 Days)
  • XOMAP N/A
  • TALKW 64.2K
  • Earning Date
  • XOMAP N/A
  • TALKW 02-20-2025
  • Dividend Yield
  • XOMAP N/A
  • TALKW N/A
  • EPS Growth
  • XOMAP N/A
  • TALKW N/A
  • EPS
  • XOMAP N/A
  • TALKW N/A
  • Revenue
  • XOMAP N/A
  • TALKW $181,291,000.00
  • Revenue This Year
  • XOMAP N/A
  • TALKW N/A
  • Revenue Next Year
  • XOMAP N/A
  • TALKW N/A
  • P/E Ratio
  • XOMAP N/A
  • TALKW N/A
  • Revenue Growth
  • XOMAP N/A
  • TALKW 31.50
  • 52 Week Low
  • XOMAP N/A
  • TALKW $0.20
  • 52 Week High
  • XOMAP N/A
  • TALKW $0.24
  • Technical
  • Relative Strength Index (RSI)
  • XOMAP 47.68
  • TALKW N/A
  • Support Level
  • XOMAP $25.57
  • TALKW N/A
  • Resistance Level
  • XOMAP $25.83
  • TALKW N/A
  • Average True Range (ATR)
  • XOMAP 0.11
  • TALKW 0.00
  • MACD
  • XOMAP -0.01
  • TALKW 0.00
  • Stochastic Oscillator
  • XOMAP 24.24
  • TALKW 0.00

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About TALKW Talkspace Inc. Warrant

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

Share on Social Networks: